TY - JOUR AU - Amadori, D. AU - Silvestrini, R. PY - 1998 DA - 1998// TI - Prognostic and predictive value of thymidine labelling index in breast cancer JO - Breast Cancer Res Treat VL - 51 UR - https://doi.org/10.1023/A:1006140629766 DO - 10.1023/A:1006140629766 ID - Amadori1998 ER - TY - JOUR AU - Rew, D. A. AU - Wilson, G. D. PY - 2000 DA - 2000// TI - Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations JO - Eur J Surg Oncol VL - 26 UR - https://doi.org/10.1053/ejso.1999.0781 DO - 10.1053/ejso.1999.0781 ID - Rew2000 ER - TY - JOUR AU - Goodson, W. H. AU - Moore, D. H. AU - Ljung, B. M. AU - Chew, K. AU - Mayall, B. AU - Smith, H. S. AU - Waldman, F. M. PY - 2000 DA - 2000// TI - The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67 JO - Breast Cancer Res Treat VL - 59 UR - https://doi.org/10.1023/A:1006344010050 DO - 10.1023/A:1006344010050 ID - Goodson2000 ER - TY - JOUR AU - Yarden, Y. AU - Sliwkowski, M. X. PY - 2001 DA - 2001// TI - Untangling the ErbB signalling network JO - Nat Rev Mol Cell Biol VL - 2 UR - https://doi.org/10.1038/35052073 DO - 10.1038/35052073 ID - Yarden2001 ER - TY - JOUR AU - Lemoine, N. R. AU - Barnes, D. M. AU - Hollywood, D. P. AU - Hughes, C. M. AU - Smith, P. AU - Dublin, E. AU - Prigent, S. A. AU - Gullick, W. J. AU - Hurst, H. C. PY - 1992 DA - 1992// TI - Expression of the ERBB3 gene product in breast cancer JO - Br J Cancer VL - 66 UR - https://doi.org/10.1038/bjc.1992.420 DO - 10.1038/bjc.1992.420 ID - Lemoine1992 ER - TY - JOUR AU - Sainsbury, J. R. AU - Farndon, J. R. AU - Sherbet, G. V. AU - Harris, A. L. PY - 1985 DA - 1985// TI - Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(85)91385-6 DO - 10.1016/S0140-6736(85)91385-6 ID - Sainsbury1985 ER - TY - JOUR AU - Suo, Z. AU - Risberg, B. AU - Kalsson, M. G. AU - Willman, K. AU - Tierens, A. AU - Skovlund, E. AU - Nesland, J. M. PY - 2002 DA - 2002// TI - EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1003 DO - 10.1002/path.1003 ID - Suo2002 ER - TY - JOUR AU - Slamon, D. J. AU - Clark, G. M. AU - Wong, S. G. AU - Levin, W. J. AU - Ullrich, A. AU - McGuire, W. L. PY - 1987 DA - 1987// TI - Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene JO - Science VL - 235 UR - https://doi.org/10.1126/science.3798106 DO - 10.1126/science.3798106 ID - Slamon1987 ER - TY - JOUR AU - Witton, C. J. AU - Reeves, J. R. AU - Going, J. J. AU - Cooke, T. G. AU - Bartlett, J. M. PY - 2003 DA - 2003// TI - Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer JO - J Pathol VL - 200 UR - https://doi.org/10.1002/path.1370 DO - 10.1002/path.1370 ID - Witton2003 ER - TY - JOUR AU - Alroy, I. AU - Yarden, Y. PY - 1997 DA - 1997// TI - The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions JO - FEBS Lett VL - 410 UR - https://doi.org/10.1016/S0014-5793(97)00412-2 DO - 10.1016/S0014-5793(97)00412-2 ID - Alroy1997 ER - TY - JOUR AU - Klijn, J. G. AU - Berns, P. M. AU - Schmitz, P. I. AU - Foekens, J. A. PY - 1992 DA - 1992// TI - The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients JO - Endocr Rev VL - 13 ID - Klijn1992 ER - TY - JOUR AU - Ross, J. S. AU - Fletcher, J. A. PY - 1998 DA - 1998// TI - The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy JO - Stem Cells VL - 16 UR - https://doi.org/10.1002/stem.160413 DO - 10.1002/stem.160413 ID - Ross1998 ER - TY - JOUR AU - Cooke, T. AU - Reeves, J. AU - Lannigan, A. AU - Stanton, P. PY - 2001 DA - 2001// TI - The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(00)00402-0 DO - 10.1016/S0959-8049(00)00402-0 ID - Cooke2001 ER - TY - JOUR AU - Sainsbury, J. R. AU - Farndon, J. R. AU - Needham, G. K. AU - Malcolm, A. J. AU - Harris, A. L. PY - 1987 DA - 1987// TI - Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer JO - Lancet VL - 1 ID - Sainsbury1987 ER - TY - JOUR AU - Naidu, R. AU - Yadav, M. AU - Nair, S. AU - Kutty, M. K. PY - 1998 DA - 1998// TI - Expression of c-erbB3 protein in primary breast carcinomas JO - Br J Cancer VL - 78 UR - https://doi.org/10.1038/bjc.1998.689 DO - 10.1038/bjc.1998.689 ID - Naidu1998 ER - TY - JOUR AU - Travis, A. AU - Pinder, S. E. AU - Robertson, J. F. AU - Bell, J. A. AU - Wencyk, P. AU - Gullick, W. J. AU - Nicholson, R. I. AU - Poller, D. N. AU - Blamey, R. W. AU - Elston, C. W. AU - Ellis, I. O. PY - 1996 DA - 1996// TI - C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators JO - Br J Cancer VL - 74 UR - https://doi.org/10.1038/bjc.1996.342 DO - 10.1038/bjc.1996.342 ID - Travis1996 ER - TY - JOUR AU - Pawlowski, V. AU - Revillion, F. AU - Hebbar, M. AU - Hornez, L. AU - Peyrat, J. P. PY - 2000 DA - 2000// TI - Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay JO - Clin Cancer Res VL - 6 ID - Pawlowski2000 ER - TY - JOUR AU - Quinn, C. M. AU - Ostrowski, J. L. AU - Lane, S. A. AU - Loney, D. P. AU - Teasdale, J. AU - Benson, F. A. PY - 1994 DA - 1994// TI - c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival JO - Histopathology VL - 25 UR - https://doi.org/10.1111/j.1365-2559.1994.tb01324.x DO - 10.1111/j.1365-2559.1994.tb01324.x ID - Quinn1994 ER - TY - JOUR AU - Knowlden, J. M. AU - Gee, J. M. AU - Seery, L. T. AU - Farrow, L. AU - Gullick, W. J. AU - Ellis, I. O. AU - Blamey, R. W. AU - Robertson, J. F. AU - Nicholson, R. I. PY - 1998 DA - 1998// TI - c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1202107 DO - 10.1038/sj.onc.1202107 ID - Knowlden1998 ER - TY - JOUR AU - Suo, Z. AU - Risberg, B. AU - Kalsson, M. G. AU - Willman, K. AU - Tierens, A. AU - Skovlund, E. AU - Nesland, J. M. PY - 2002 DA - 2002// TI - EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1003 DO - 10.1002/path.1003 ID - Suo2002 ER - TY - JOUR AU - Stanton, P. D. AU - Cooke, T. G. AU - Forster, G. AU - Smith, D. AU - Going, J. J. PY - 1996 DA - 1996// TI - Cell kinetics in vivo of human breast cancer JO - Br J Surg VL - 83 UR - https://doi.org/10.1002/bjs.1800830130 DO - 10.1002/bjs.1800830130 ID - Stanton1996 ER - TY - JOUR AU - Frierson, H. F. PY - 1991 DA - 1991// TI - Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast JO - Am J Surg Pathol VL - 15 UR - https://doi.org/10.1097/00000478-199104000-00004 DO - 10.1097/00000478-199104000-00004 ID - Frierson1991 ER - TY - JOUR AU - Tubiana, M. AU - Pejovic, M. H. AU - Chavaudra, N. AU - Contesso, G. AU - Malaise, E. P. PY - 1984 DA - 1984// TI - The long-term prognostic significance of the thymidine labelling index in breast cancer JO - Int J Cancer VL - 33 UR - https://doi.org/10.1002/ijc.2910330404 DO - 10.1002/ijc.2910330404 ID - Tubiana1984 ER - TY - JOUR AU - Cooke, T. G. AU - Stanton, P. D. AU - Winstanley, J. AU - Murray, G. D. AU - Croton, R. AU - Holt, S. AU - George, W. D. PY - 1992 DA - 1992// TI - Long-term prognostic significance of thymidine labelling index in primary breast cancer JO - Eur J Cancer VL - 28 UR - https://doi.org/10.1016/S0959-8049(05)80067-X DO - 10.1016/S0959-8049(05)80067-X ID - Cooke1992 ER - TY - JOUR AU - Stanton, P. D. AU - Cooke, T. G. AU - Oakes, S. J. AU - Winstanley, J. AU - Holt, S. AU - George, W. D. AU - Murray, G. D. PY - 1992 DA - 1992// TI - Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer JO - Br J Cancer VL - 66 UR - https://doi.org/10.1038/bjc.1992.387 DO - 10.1038/bjc.1992.387 ID - Stanton1992 ER - TY - JOUR AU - Gerdes, J. AU - Lemke, H. AU - Baisch, H. AU - Wacker, H. H. AU - Schwab, U. AU - Stein, H. PY - 1984 DA - 1984// TI - Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 JO - J Immunol VL - 133 ID - Gerdes1984 ER - TY - JOUR AU - Begg, A. C. AU - McNally, N. J. AU - Shrieve, D. C. AU - Karcher, H. PY - 1985 DA - 1985// TI - A method to measure the duration of DNA synthesis and the potential doubling time from a single sample JO - Cytometry VL - 6 UR - https://doi.org/10.1002/cyto.990060618 DO - 10.1002/cyto.990060618 ID - Begg1985 ER - TY - JOUR AU - White, R. A. AU - Terry, N. H. AU - Meistrich, M. L. AU - Calkins, D. P. PY - 1990 DA - 1990// TI - Improved method for computing potential doubling time from flow cytometric data JO - Cytometry VL - 11 UR - https://doi.org/10.1002/cyto.990110214 DO - 10.1002/cyto.990110214 ID - White1990 ER - TY - JOUR AU - Cutress, R. I. AU - Mullee, M. A. AU - Royle, G. T. AU - Rew, D. A. PY - 2000 DA - 2000// TI - Clinical outcome and bromodeoxyuridine-derived proliferation indices in 75 invasive breast carcinomas JO - Eur J Surg Oncol VL - 26 UR - https://doi.org/10.1053/ejso.2000.0997 DO - 10.1053/ejso.2000.0997 ID - Cutress2000 ER - TY - JOUR AU - van de Vijver, M. J. AU - He, Y. D. AU - van't Veer, L. J. AU - Dai, H. AU - Hart, A. A. AU - Voskuil, D. W. AU - Schreiber, G. J. AU - Peterse, J. L. AU - Roberts, C. AU - Marton, M. J. AU - Parrish, M. AU - Atsma, D. AU - Witteveen, A. AU - Glas, A. AU - Delahaye, L. AU - van d, V. AU - Bartelink, H. AU - Rodenhuis, S. AU - Rutgers, E. T. AU - Friend, S. H. AU - Bernards, R. PY - 2002 DA - 2002// TI - A gene-expression signature as a predictor of survival in breast cancer JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa021967 DO - 10.1056/NEJMoa021967 ID - van de Vijver2002 ER - TY - JOUR AU - Robertson, K. W. AU - Reeves, J. R. AU - Smith, G. AU - Keith, W. N. AU - Ozanne, B. W. AU - Cooke, T. G. AU - Stanton, P. D. PY - 1996 DA - 1996// TI - Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer JO - Cancer Res VL - 56 ID - Robertson1996 ER - TY - JOUR AU - Nicholson, R. I. AU - McClelland, R. A. AU - Finlay, P. AU - Eaton, C. L. AU - Gullick, W. J. AU - Dixon, A. R. AU - Robertson, J. F. AU - Ellis, I. O. AU - Blamey, R. W. PY - 1993 DA - 1993// TI - Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity JO - Eur J Cancer VL - 29A UR - https://doi.org/10.1016/S0959-8049(05)80215-1 DO - 10.1016/S0959-8049(05)80215-1 ID - Nicholson1993 ER - TY - JOUR AU - Sauter, G. AU - Haley, J. AU - Chew, K. AU - Kerschmann, R. AU - Moore, D. AU - Carroll, P. AU - Moch, H. AU - Gudat, F. AU - Mihatsch, M. J. AU - Waldman, F. PY - 1994 DA - 1994// TI - Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer JO - Int J Cancer VL - 57 UR - https://doi.org/10.1002/ijc.2910570412 DO - 10.1002/ijc.2910570412 ID - Sauter1994 ER - TY - JOUR AU - Moriki, T. AU - Takahashi, T. AU - Kataoka, H. AU - Hiroi, M. AU - Yamane, T. AU - Hara, H. PY - 1996 DA - 1996// TI - Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status JO - Pathol Int VL - 46 UR - https://doi.org/10.1111/j.1440-1827.1996.tb03574.x DO - 10.1111/j.1440-1827.1996.tb03574.x ID - Moriki1996 ER - TY - JOUR AU - Ioachim, E. AU - Kamina, S. AU - Athanassiadou, S. AU - Agnantis, N. J. PY - 1996 DA - 1996// TI - The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer JO - Anticancer Res VL - 16 ID - Ioachim1996 ER - TY - JOUR AU - Dowsett, M. AU - Harper-Wynne, C. AU - Boeddinghaus, I. AU - Salter, J. AU - Hills, M. AU - Dixon, M. AU - Ebbs, S. AU - Gui, G. AU - Sacks, N. AU - Smith, I. PY - 2001 DA - 2001// TI - HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer JO - Cancer Res VL - 61 ID - Dowsett2001 ER - TY - JOUR AU - Tang, C. K. AU - Concepcion, X. Z. AU - Milan, M. AU - Gong, X. AU - Montgomery, E. AU - Lippman, M. E. PY - 1999 DA - 1999// TI - Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo JO - Cancer Res VL - 59 ID - Tang1999 ER - TY - JOUR AU - Wang, L. M. AU - Kuo, A. AU - Alimandi, M. AU - Veri, M. C. AU - Lee, C. C. AU - Kapoor, V. AU - Ellmore, N. AU - Chen, X. H. AU - Pierce, J. H. PY - 1998 DA - 1998// TI - ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4 JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.12.6809 DO - 10.1073/pnas.95.12.6809 ID - Wang1998 ER - TY - JOUR AU - Sartor, C. I. AU - Zhou, H. AU - Kozlowska, E. AU - Guttridge, K. AU - Kawata, E. AU - Caskey, L. AU - Harrelson, J. AU - Hynes, N. AU - Ethier, S. AU - Calvo, B. AU - Earp, H. S. PY - 2001 DA - 2001// TI - Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells JO - Mol Cell Biol VL - 21 UR - https://doi.org/10.1128/MCB.21.13.4265-4275.2001 DO - 10.1128/MCB.21.13.4265-4275.2001 ID - Sartor2001 ER - TY - JOUR AU - Jones, F. E. AU - Welte, T. AU - Fu, X. Y. AU - Stern, D. F. PY - 1999 DA - 1999// TI - ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation JO - J Cell Biol VL - 147 UR - https://doi.org/10.1083/jcb.147.1.77 DO - 10.1083/jcb.147.1.77 ID - Jones1999 ER - TY - JOUR AU - Gullick, W. J. PY - 2003 DA - 2003// TI - c-erbB-4/HER4: friend or foe? JO - J Pathol VL - 200 UR - https://doi.org/10.1002/path.1335 DO - 10.1002/path.1335 ID - Gullick2003 ER - TY - JOUR AU - Baselga, J. PY - 2001 DA - 2001// TI - Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials JO - Oncology VL - 61 UR - https://doi.org/10.1159/000055397 DO - 10.1159/000055397 ID - Baselga2001 ER -